Surprisingly, these studies in canine lymphoma cells reported no changes in the expression levels of XIAP, Mcl-1, Bcl-2, and Bcl-xL proteins following treatment with either flavopiridol alone or with the combination of flavopiridol and human TRAIL. This evidence concerns the gene BCL2L1 and lymphoma.